Your Location:
Home >
Browse articles >
Effect of Yiqi Huoxue Prescription on cAMP/Epac1/Rap1 Signaling Pathway in Coronary Heart Disease Rats with Qi Deficiency and Blood Stasis Syndrome
Updated:2024-08-21
    • Effect of Yiqi Huoxue Prescription on cAMP/Epac1/Rap1 Signaling Pathway in Coronary Heart Disease Rats with Qi Deficiency and Blood Stasis Syndrome

      Enhanced Publication
    • “The latest research has found that Yiqi Huoxue Formula effectively improves the heart function of rats with coronary heart disease Qi deficiency and blood stasis syndrome by regulating the cAMP/Epac1/Rap1 signaling pathway, reducing blood viscosity and plasma cAMP content, decreasing collagen fiber proliferation, and improving myocardial injury.”
    • WU Huaying , DENG Kai , LI Jing , MAO Yizhi , LI Liang , PENG Qinghua
    • Chinese Journal of Experimental Traditional Medical Formulae Vol. 30, Issue 18, Pages: 107-116(2024)
    • DOI: 10.13422/j.cnki.syfjx.20231819     

      CLC:

    Scan QR Code

  •  
  •  
  • AI Introduction

  • Full Text(HTML)

  • Figs( 5 ) Tabs( 7 )

  • References

  • Publication Info

  • Metrics

292

Views

321

Downloads

3

CSCD

Alert me when the article has been cited
Submit
Tools
  • BibTeXDownload
  • EndnoteDownload
  • RefMan Download
  • NoteExpressDownload
  • NoteFirstDownload

Related Articles

Meaning, Efficacy and Mechanism of Huoxin Pills in Treating Coronary Heart Disease with Qi Deficiency and Blood Stasis Syndrome
Correlations Between Severity of Heart Failure Related to Coronary Heart Disease of Qi Deficiency and Blood Stasis Syndrome and Biological Indexes
Mechanism of Yiqi Huoxue Decoction in Treating Coronary Heart Disease with Qi Deficiency and Blood Stasis Syndrome
Traditional Chinese Medicine Treats Coronary Heart Disease by Intervening in Cardiovascular Cell Apoptosis: A Review
Effect and Mechanism of Liangyi Paste on Hepatic Lipid Deposition in Naturally Aged Mice with High-fat Diet via Cuproptosis/Oxidative Stress Pathway

Related Author

YANG Xiu-juan
ZHU Rui-xuan
XIE Ran
YANG Lei
CHEN Jin-cheng
XU bao-xin
SHI Xiao-chun
WANG Peng-qian

Related Institution

Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences
Youcare Pharmaceutical Group Co. Ltd.
Henan University of Chinese Medicine
The First Affiliated Hospital of Henan University of Chinese Medicine
The Second Clinical Medical College, Heilongjiang University of Chinese Medicine